Characterization and outcome following Puumala virus infection: a retrospective analysis of 75 cases.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 20223893)

Published in Nephrol Dial Transplant on March 11, 2010

Authors

Niko Braun1, Michael Haap, Dietrich Overkamp, Martin Kimmel, Mark Dominik Alscher, Hendrik Lehnert, Christian S Haas

Author Affiliations

1: Department of Internal Medicine IV, Division of General Internal Medicine and Nephrology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.

Articles citing this

Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol (2011) 1.09

Sex differences in the incidence and case fatality rates from hemorrhagic fever with renal syndrome in China, 2004-2008. Clin Infect Dis (2011) 1.01

Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection. PLoS One (2013) 0.87

Detection of Puumala hantavirus antigen in human intestine during acute hantavirus infection. PLoS One (2014) 0.80

Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, Germany. Emerg Infect Dis (2015) 0.80

Hantavirus infection: a neglected diagnosis in thrombocytopenia and fever? Mayo Clin Proc (2010) 0.80

More novel hantaviruses and diversifying reservoir hosts--time for development of reservoir-derived cell culture models? Viruses (2014) 0.79

Urine soluble urokinase-type plasminogen activator receptor levels correlate with proteinuria in Puumala hantavirus infection. J Intern Med (2014) 0.78

Evaluation of lipase levels in patients with nephropathia epidemica--no evidence for acute pancreatitis. BMC Infect Dis (2015) 0.78

Hyperintense lesion in the corpus callosum associated with Puumala hantavirus infection. J Neurol (2012) 0.78

'Bedside assessment' of acute hantavirus infections and their possible classification into the spectrum of haemophagocytic syndromes. Eur J Clin Microbiol Infect Dis (2016) 0.76

Should we recommend precautions during a hantavirus endemic? NDT Plus (2010) 0.75

Puumala Hantavirus-Induced Hemorrhagic Fever with Renal Syndrome Must Be Considered across the Borders of Nephrology to Avoid Unnecessary Diagnostic Procedures. PLoS One (2015) 0.75

Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and proteinuria predict severity of acute kidney injury in Puumala virus infection. BMC Infect Dis (2015) 0.75

Articles by these authors

Short-term sleep loss decreases physical activity under free-living conditions but does not increase food intake under time-deprived laboratory conditions in healthy men. Am J Clin Nutr (2009) 3.20

The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab (2010) 3.12

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes (2003) 2.71

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32

Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer (2004) 2.20

Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. Curr Drug Metab (2009) 2.17

Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab (2006) 1.87

1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol (2003) 1.86

Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant (2007) 1.86

Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging (2005) 1.85

Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology (2006) 1.80

Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab (2003) 1.58

Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum (2005) 1.58

Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab (2007) 1.58

Disturbed glucoregulatory response to food intake after moderate sleep restriction. Sleep (2011) 1.55

Mitochondrial gene polymorphisms that protect mice from colitis. Gastroenterology (2013) 1.53

Difference in the expression of hormone receptors and fibrotic markers in the human peritoneum--implications for therapeutic targets to prevent encapsulating peritoneal sclerosis. Perit Dial Int (2011) 1.51

Clinical review: Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab (2007) 1.51

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens (2004) 1.48

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA (2012) 1.47

Coronary artery spasm as a cause for myocardial infarction in patients with systemic inflammatory disease. Int J Cardiol (2011) 1.43

The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: role of the newly established pro-inflammatory adipokine Acute-phase Serum Amyloid A; evidence of an adipose tissue-monocyte axis. Atherosclerosis (2010) 1.43

High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens (2004) 1.43

Phaeochromocytoma, new genes and screening strategies. Clin Endocrinol (Oxf) (2006) 1.41

The expression patterns of peritoneal defensins. Perit Dial Int (2007) 1.39

Interaction of tumor cells with the microenvironment. Cell Commun Signal (2011) 1.38

Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes (2008) 1.34

Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood (2005) 1.32

Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One (2012) 1.30

Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Mol Cancer (2011) 1.30

Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology (2010) 1.30

Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care (2002) 1.29

Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. BMC Genomics (2009) 1.29

Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes (2009) 1.25

Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab (2007) 1.24

[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care]. Med Klin (Munich) (2006) 1.22

Circadian desynchrony promotes metabolic disruption in a mouse model of shiftwork. PLoS One (2012) 1.20

Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther (2006) 1.19

Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes (2008) 1.18

Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Cardiovasc Res (2009) 1.17

Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. J Clin Endocrinol Metab (2003) 1.17

The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum (2007) 1.16

Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab (2005) 1.16

Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. J Clin Psychopharmacol (2004) 1.15

CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum (2006) 1.13

High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity (Silver Spring) (2007) 1.13

Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes (2012) 1.12

Metastatic paraganglioma. Semin Oncol (2010) 1.12

Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control. Psychother Psychosom (2010) 1.09

Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. J Clin Endocrinol Metab (2010) 1.09

Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol (2007) 1.08

Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes (2010) 1.07

Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications (2006) 1.06

Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05

Effects of selective slow-wave sleep deprivation on nocturnal blood pressure dipping and daytime blood pressure regulation. Am J Physiol Regul Integr Comp Physiol (2009) 1.04

Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men. Diabetes (2010) 1.02

Differences between students and physicians in their entitlement towards procedural skills education--a needs assessment of skills training in internal medicine. GMS Z Med Ausbild (2012) 1.02

Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Diabetes (2011) 1.01

Sympathetic function in human carriers of melanocortin-4 receptor gene mutations. J Clin Endocrinol Metab (2010) 1.00

Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects. Diabetes Care (2004) 1.00

Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis. Nephrol Dial Transplant (2010) 1.00

Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care (2005) 0.98

How the selfish brain organizes its supply and demand. Front Neuroenergetics (2010) 0.98

What you should know about the work-up of a renal biopsy. Nephrol Dial Transplant (2006) 0.97

The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1beta. Endocrinology (2007) 0.96

The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease. Am J Pathol (2010) 0.96

Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol Endocrinol (2007) 0.96

Endotoxemia causes central downregulation of sympathetic vasomotor tone in healthy humans. Am J Physiol Regul Integr Comp Physiol (2008) 0.96

Histological criteria for encapsulating peritoneal sclerosis - a standardized approach. PLoS One (2012) 0.96

Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 0.96

Metastatic glucagonoma: treatment with liver transplantation. J Am Acad Dermatol (2006) 0.95

Gallstone ileus. Clin Gastroenterol Hepatol (2011) 0.95

Phenotypes of encapsulating peritoneal sclerosis--macroscopic appearance, histologic findings, and outcome. Perit Dial Int (2013) 0.95

Oxytocin reduces reward-driven food intake in humans. Diabetes (2013) 0.94

Encapsulating peritoneal sclerosis - an overview. Nephrol Ther (2011) 0.94

Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis. Arthritis Rheum (2013) 0.94

Cold-induced alteration of adipokine profile in humans. Metabolism (2010) 0.93

High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology (2010) 0.93

The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obes Res (2005) 0.93

Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma. J Clin Endocrinol Metab (2003) 0.93

Circadian clock genes Per1 and Per2 regulate the response of metabolism-associated transcripts to sleep disruption. PLoS One (2012) 0.93

Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B. J Endocrinol (2009) 0.93

Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases. Ann Rheum Dis (2010) 0.92

Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med (2003) 0.92

Restricted expression of mouse GCMa/Gcm1 in kidney and thymus. Mech Dev (2002) 0.91

The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells. Cancer Chemother Pharmacol (2012) 0.91

Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study. Clin Res Cardiol (2013) 0.89

Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d. Mol Endocrinol (2008) 0.89

Experimental hyperleptinemia acutely increases vasoconstrictory sympathetic nerve activity in healthy humans. J Clin Endocrinol Metab (2013) 0.89

Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO). Endocrinology (2011) 0.89

Rac1b negatively regulates TGF-β1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling. Oncotarget (2014) 0.88

Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis (2003) 0.88

Leptin and the skin: a new frontier. Exp Dermatol (2009) 0.87

Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity: implications for atypical antipsychotics. Psychosom Med (2005) 0.87

Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany. Nephrol Dial Transplant (2012) 0.87

H-2g, a glucose analog of blood group H antigen, mediates mononuclear cell recruitment via Src and phosphatidylinositol 3-kinase pathways. Arthritis Rheum (2008) 0.87

High cut-off renal replacement therapy for removal of myoglobin in severe rhabdomyolysis and acute kidney injury: a case series. Nephron Clin Pract (2013) 0.87

Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes. Diabetes Care (2003) 0.87

Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab (2011) 0.86